Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Laboratorios Farmacéuticos ROVI, S.A. has received non-binding offers for the purchase of its contract manufacturing business, as part of its strategic evaluation to enhance asset value. The proposals are subject to customary conditions including due diligence and satisfactory contract negotiations. The company will continue to assess the potential transaction’s fit, with any proceeding decision contingent on shareholder approval and regulatory authorization.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.